Trial Profile
A Study to Evaluate the Effects of Intravitreal Ranibizumab on Retinal Fluid and Visual Acuity in Patients With Exudative Age Related Macular Degeneration
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 08 Jun 2016 New trial record